DE69330246T2 - Impfstoffe auf der basis von streptokinase - Google Patents

Impfstoffe auf der basis von streptokinase

Info

Publication number
DE69330246T2
DE69330246T2 DE69330246T DE69330246T DE69330246T2 DE 69330246 T2 DE69330246 T2 DE 69330246T2 DE 69330246 T DE69330246 T DE 69330246T DE 69330246 T DE69330246 T DE 69330246T DE 69330246 T2 DE69330246 T2 DE 69330246T2
Authority
DE
Germany
Prior art keywords
pct
streptokinase
activating
plasminogen
protein produced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69330246T
Other languages
English (en)
Other versions
DE69330246D1 (de
Inventor
James Andrew Leigh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of DE69330246D1 publication Critical patent/DE69330246D1/de
Publication of DE69330246T2 publication Critical patent/DE69330246T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3153—Streptokinase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE69330246T 1992-01-17 1993-01-18 Impfstoffe auf der basis von streptokinase Expired - Fee Related DE69330246T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929201013A GB9201013D0 (en) 1992-01-17 1992-01-17 Vaccines
PCT/GB1993/000110 WO1993014209A1 (en) 1992-01-17 1993-01-18 Vaccines based on streptokinase

Publications (2)

Publication Number Publication Date
DE69330246D1 DE69330246D1 (de) 2001-06-28
DE69330246T2 true DE69330246T2 (de) 2001-12-06

Family

ID=10708771

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69330246T Expired - Fee Related DE69330246T2 (de) 1992-01-17 1993-01-18 Impfstoffe auf der basis von streptokinase

Country Status (13)

Country Link
US (1) US5840315A (de)
EP (1) EP0623170B1 (de)
JP (1) JP3234226B2 (de)
AT (1) ATE201448T1 (de)
AU (1) AU673344B2 (de)
CA (1) CA2128247C (de)
DE (1) DE69330246T2 (de)
DK (1) DK0623170T3 (de)
ES (1) ES2158857T3 (de)
GB (1) GB9201013D0 (de)
GR (1) GR3036369T3 (de)
PT (1) PT623170E (de)
WO (1) WO1993014209A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL129566A0 (en) * 1996-11-14 2000-02-29 Univ Saskatchewan Streptococcus uberis lactoferrin-binding protein
US6485904B1 (en) * 1997-06-23 2002-11-26 Pfizer, Inc. DNA encoding a plasminogen activating protein
DK1035133T3 (da) 1999-02-17 2005-05-02 Pfizer Prod Inc Fusionsproteiner, der omfatter bærere, som kan inducere et dobbelt immunrespons
NZ507335A (en) * 2000-10-05 2004-10-29 New Zealand Dairy Board Bone health compositions derived from milk comprising an acidic protein fraction but that does not contain CGMP
GB2419136A (en) * 2004-10-12 2006-04-19 Danisco Auxotrophic Streptococcus bacteria
US10618084B2 (en) 2018-01-22 2020-04-14 Terydon, Inc. Reaction force nozzle

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021541A (en) * 1975-10-20 1977-05-03 New York Medical College Antigen isolated from group A (beta-hemolytic) streptococci and method for isolating the same
US4425330A (en) * 1981-05-20 1984-01-10 Cornell Research Foundation, Inc. Bovine mastitis vaccine and method for detecting efficacy thereof
US4675176A (en) * 1983-12-12 1987-06-23 Norden Laboratories Moraxella bovis protease vaccine
IN164864B (de) * 1985-05-13 1989-06-24 Commw Scient Ind Res Org
US5198215A (en) * 1987-06-22 1993-03-30 Noordzee Laboratorium N.V. Composition for controlling mastitis in ruminants, method for its preparation and method of treatment of ruminants
DK130889A (da) * 1989-03-17 1990-09-18 Mogens Kilian Immunoglobulin a1-proteaser (iga1-proteaser), fremgangsmaade til genteknologisk fremstilling af saadanne enzymer samt vaccine indeholdende enzymerne og fragmenter deraf til immunisering mod bakteriel meningitis og andre sygdomme fremkaldt af iga1-protease-producerende bakterier
US5240845A (en) * 1989-07-11 1993-08-31 Otsuka Pharmaceutical Factory, Ltd. Mutated streptokinase proteins

Also Published As

Publication number Publication date
AU3360193A (en) 1993-08-03
AU673344B2 (en) 1996-11-07
US5840315A (en) 1998-11-24
DE69330246D1 (de) 2001-06-28
GB9201013D0 (en) 1992-03-11
WO1993014209A1 (en) 1993-07-22
EP0623170A1 (de) 1994-11-09
CA2128247A1 (en) 1993-07-22
PT623170E (pt) 2001-11-30
DK0623170T3 (da) 2001-09-10
ATE201448T1 (de) 2001-06-15
GR3036369T3 (en) 2001-11-30
JPH07504166A (ja) 1995-05-11
ES2158857T3 (es) 2001-09-16
JP3234226B2 (ja) 2001-12-04
CA2128247C (en) 2002-09-10
EP0623170B1 (de) 2001-05-23

Similar Documents

Publication Publication Date Title
DE69130289T2 (de) Therapeutische verwendung von actin-bindenden verbindungen
FI960977A0 (fi) Bakteeriperäiset eksportoidut proteiinit ja niihin perustuvat asellulaariset rokotteet
NO963508L (no) Urease-basert vaksine og behandling av Helicobacter-infeksjon
DE69533673D1 (de) Behandlung und prävention von helicobacter-infektionen
DE69309044D1 (de) Behandlung von asthma
DE3582272D1 (de) Antigenische zubereitungen und isolierung von solchen zubereitungen.
DE69410254D1 (de) Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente
ATE92717T1 (de) Verfahren zur verbesserung der wirksamkeit von insektentoxinen.
DK162421C (da) Hundeparvovirus-vaccine, fremgangsmaade til fremstilling heraf og virusstamme til brug i vaccinen
DE69330246T2 (de) Impfstoffe auf der basis von streptokinase
Mebs et al. Snake venom hemorrhagins: neutralization by commercial antivenoms
DK1666057T3 (da) Fremgangsmåde til fremstilling af en acellulær vaccine indeholdende Bordetella pertussis antigener
PT600396E (pt) Vacinas contra protozoarios intestinais
ATE432287T1 (de) Peptidfragmente mit den zelltod verhindernder aktivität
ATE374246T1 (de) Polypeptidfragmente mit einem c-terminalen teil von katalase aus helicobacter
DE3883315D1 (de) Neue fibrinolytische enzyme.
EP0145486A3 (de) Mikrobiologisches Verfahren
ATE286405T1 (de) Verfahren zur verhütung der nebenwirkungen und unempfindlichkeit gegenüber therapeutischen verwendungen von toxinen
DE69827163D1 (de) Phytase zur vorbeugung oder behandlung von mastitis
DE69413952D1 (de) Extraktion von zellgebundenem protein von bordetella
ATE318300T1 (de) Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe
DK128687D0 (da) Proteiner samt deres fremstilling og anvendelse
ATE159758T1 (de) Azelluläre impfstoffe

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee